LinkedIn Icon
October 22-24, 2018
London, UK




Pre Conference Workshop
Monday 22 October 2018

13.00 - 16.00
Overcoming Analytical Challenges Encountered Throughout the Development of Gene Therapies
Workshop Leader: Christine Le Bec, Head of CMC Analytics, Genethon

As an increasing number of gene therapy products progress into the advanced stages of development, the role of analytical testing is becoming increasingly crucial. These tests are invaluable in clarifying the quality of products and mitigating against unexpected delays at every stage of this development journey.
Join us to learn about:

  • The unique analytical challenges posed by the complexity of gene therapy products
  • Quality attributes that need to be closely monitored throughout gene therapy drug development, including potency, purity, safety, stability and efficacy
  • The design of analytical assays in the context of the current EU regulatory framework

Christine Le Bec, Head of CMC Analytics, Genethon